CD44 isoforms in prognosis of breast cancer.
Kaufmann
M
M
Heider
K H
KH
Sinn
H P
HP
von Minckwitz
G
G
Ponta
H
H
Herrlich
P
P
D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000401:mortality; D002277:Carcinoma / Q000175:diagnosis* / Q000401:mortality; D002352:Carrier Proteins / Q000032:analysis*; D000939:Epitopes / Q000032:analysis; D005260:Female; D006801:Humans; D018960:Hyaluronan Receptors; D007519:Isoantigens / Q000032:analysis*; D011379:Prognosis; D011956:Receptors, Cell Surface / Q000032:analysis*; D016201:Receptors, Lymphocyte Homing / Q000032:analysis*
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002352:Carrier Proteins; D000939:Epitopes; D018960:Hyaluronan Receptors; D007519:Isoantigens; D011956:Receptors, Cell Surface; D016201:Receptors, Lymphocyte Homing